Analyst Price Target is $18.38
▲ +102.59% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for SELLAS Life Sciences Group in the last 3 months. The average price target is $18.38, with a high forecast of $21.00 and a low forecast of $16.50. The average price target represents a 102.59% upside from the last price of $9.07.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in SELLAS Life Sciences Group.